1. Used to prepare makeups with anti-aging results
CN201611046133.8 offers a structure with an anti-aging effect, so pertaining to increase the flexibility as well as radiance of the skin, along with reward prostatic hyperplasia, hypercholesterolemia, arteriosclerosis, impotence, as well as also menopause and postmenopause. Purpose of Signs and symptoms.
In order to attain the above item, today development adopts the adhering to technological service: a make-up with anti-aging effect, characterized in that the structure with anti-aging result contains daidzein, daidzein, genistin, genistein and also puerarin, Amongst them, the weight proportion of daidzein, daidzein, genistein, genistein as well as also puerarin is (3 * 104-7 * 104): (6-10): (0.8 * 104-1.5 * 104): (1 -3): (80-110). The make-up of the present moment innovation can enhance the versatility as well as appeal of the skin when utilized in the human body. In addition, the structure can be made use of for skin healthcare, breast care (consisting of breast flexibility, boob job, bust crease elimination) and also treatment of prostatic hyperplasia, hypercholesterolemia, arteriosclerosis, impotence and also menopausal as well as postmenopausal indications. Made use of in the manufacture of cosmetics, cosmeceuticals, medicinal items in addition to health care items, valuable foods, and also drinks.
2. Pharmaceutical make-ups for dealing with hyperlipidemia and atherosclerosis
CN201710312895.6 provides a pharmaceutical make-up with clear components, workable top quality, as well as likewise substantial performance for dealing with hyperlipidemia as well as atherosclerosis. The pharmaceutical cosmetics has active components, in addition to the energetic aspects are puerarin, daidzein, genistin, daidzein, callisoflavone glucoside, astragalus saponin II, astragaloside IV, formononetin, in addition to morin A. A mix of 2 or more of morin, scopolamine, mulberry C, 1-deoxynojirimycin, kudzu polysaccharide, astragalus polysaccharide as well as also mulberry bark polysaccharide. The pharmaceutical structure can reduce the place of fatty plaque in the aorta of the atherosclerosis model apoE-/- transgenic computer system mice, has the result of controling hyperlipidemia in computer mice, as well as also can take care of hyperlipidemia as well as also atherosclerosis.